Concepedia

David L. Soper

DL

Statistics

Publications

10

Citations

174

H-Index

10

Active since

2000

Affiliations

Procter & Gamble (United States)(Current)

David L. Soper is an author at Procter & Gamble (United States) specializing in medicinal chemistry, pharmacology, and drug discovery.

Publications per year

2000–2006

10

Publications

10

The Synthesis and Human FP Receptor Binding Affinity of 13,14-Dihydro Prostaglandin F1.ALPHA. Sulfonamides. Potential Treatments for Osteoporosis.

Yili Wang, David L. Soper, Michelle J. Dirr et al. · Chemical and Pharmaceutical Bulletin · 2000 · 32 citations · Full text

, , +16

Discovery of novel conformationally restricted diazocan peptidomimetics as inhibitors of interleukin-1β synthesis

Kofi A. Oppong, Christopher D. Ellis, Michael C. Laufersweiler et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 21 citations · Full text

, , +12

Synthesis and evaluation of novel 8,6-fused bicyclic peptidomimetic compounds as interleukin-1β converting enzyme inhibitors

Steven V. O’Neil, Yili Wang, Michael C. Laufersweiler et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 20 citations · Full text

, , +11

Synthesis and evaluation of unsaturated caprolactams as interleukin-1β converting enzyme (ICE) inhibitors

Yili Wang, Steven V. O’Neil, John A. Wos et al. · Bioorganic & Medicinal Chemistry · 2006 · 18 citations · Full text

, , +6

Synthesis and Biological Evaluation of Prostaglandin-F Alkylphosphinic Acid Derivatives as Bone Anabolic Agents for the Treatment of Osteoporosis

David L. Soper, Jared B. J. Milbank, Glen E. Mieling et al. · Journal of Medicinal Chemistry · 2001 · 16 citations · Full text

, , +17

1–5 of 10